跳至主要内容
临床试验/NCT07043075
NCT07043075尚未招募不适用

First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance Software Operated in Parallel Setup During Transcatheter Aortic Valve Implantation (TAVI) Without Influencing Clinical Decision-Making

Caranx Medical0 个研究点目标入组 10 人开始时间: 2025年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
10
主要终点
Investigational Device Safety

研究概览

简要总结

The trial aims to evaluate the feasibility and safety of Caranx Medical TAVIPILOT augmented reality guidance software during Transcatheter Aortic Valve Replacement Procedures.

详细描述

The study is a prospective mono-center single-arm study to evaluate primarily the feasibility and safety of TAVIPILOT augmented reality guidance software during Transcatheter Aortic Valve Replacement Procedures (TAVR) for severe aortic stenosis. A series of parameters will be analysed to determine whether TAVIPILOT is a safe tool for valve positioning.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged ≥65
  • Indicated for transfemoral TAVR for severe aortic stenosis

排除标准

  • 未提供

结局指标

主要结局

Investigational Device Safety

时间窗: Peroperative

Exploratory evaluation of the technical robustness of the Investigational Device (TaviPilot Software) by evaluating the occurence of malfunctions while operating passively in parallel of the clinical procedure

次要结局

  • Investigational Device Performance(Peroperative)

研究者

发起方
Caranx Medical
申办方类型
Industry
责任方
Sponsor

相似试验